ABSTRACT
In recent years, the production of plasma-treated water (PTW) by low-temperature low-pressure glow plasma (LPGP) has been increasingly gaining in popularity. LPGP-treated water changes its physical and physiochemical properties compared to standard distilled water. In this study, a non-conventional lipolytic yeast species Yarrowia lipolytica was cultivated in culture media based on Nantes plasma water with heightened singlet oxygen content (Nantes PW) or in water treated with low-temperature, low-pressure glow plasma while in contact with air (PWTA) or nitrogen (PWTN). The research aimed to assess the influence of culture conditions on castor oil biotransformation to gamma-decalactone (GDL) and other secondary metabolites in media based on nanowater. The Nantes plasma water-based medium attained the highest concentration of gamma-decalactone (4.81 ± 0.51 g/L at 144 h of culture), maximum biomass concentration and biomass yield from the substrate. The amplified activity of lipases in the nanowater-based medium, in comparison to the control medium, is encouraging from the perspective of GDL biosynthesis, relying on the biotransformation of ricinoleic acid, which is the primary component of castor oil. Although lipid hydrolysis was enhanced, this step seemed not crucial for GDL concentration. Interestingly, the study validates the significance of oxygen in ß-oxidation enzymes and its role in the bioconversion of ricinoleic acid to GDL and other lactones. Specifically, media with higher oxygen content (WPTA) and Nantes plasma water resulted in remarkably high concentrations of four lactones: gamma-decalactone, 3-hydroxy-gamma-decalactone, dec-2-en-4-olide and dec-3-en-4-olide.
Subject(s)
Yarrowia , Castor Oil/metabolism , Water/metabolism , Lactones/chemistry , Oxygen/metabolismABSTRACT
Ricin is a heterodimeric protein that consists of A and B subunits that can be produced in the seeds of the castor oil plant Ricinus communis. Its large quantities are accumulated in byproducts generated during the extraction of castor oil, widely used in the cosmetic and pharmaceutical industry. Ricin is one of the most potent toxins. Toxic effects of ricin are caused by its ability to inhibit protein synthesis and the level of toxicity depends on both dose and route of exposure. There are three route of administration of ricin: oral ingestion, parenteral (injectable) or inhalation. The clinical presentation of ricin toxicity depends on the route of administration. Toxin causes inflammation, gastrointestinal haemorrhages, renal tubular necrosis or hypoglycemia. Although ricin can be lethal, it has the potential for therapeutic use. Ricin A-chain is one of the first examples of a toxin coupled to monoclonal antibodies against cell surface proteins and is used experimentally for the treatment of various cancers. This article discusses the structure of ricin, the mechanism of its synthesis and describes the biological activity of this protein.
